Sono-Tek (SOTK) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for August 21, 2025, to elect four directors, ratify auditors, and hold advisory votes on executive compensation and its frequency.
Shareholders of record as of July 21, 2025, are entitled to vote; multiple voting methods are available.
Proxy materials, including the annual report, are available online and by mail.
Voting matters and shareholder proposals
Four directors nominated for election to serve until 2027; one current director not standing for reelection.
Ratification of CBIZ CPAs as independent auditors for fiscal year ending February 28, 2026.
Advisory vote on executive compensation and on the frequency of future advisory votes, with board recommending a three-year interval.
Shareholder proposals for the 2026 meeting must be submitted by April 15, 2026, following SEC and by-law procedures.
Board of directors and corporate governance
Board consists of eight members, six of whom are independent under NASDAQ rules.
Board leadership includes an Executive Chairman and a CEO/President, providing a link between management and the board.
Three standing committees: Audit, Compensation, and Nominating, each with defined charters and responsibilities.
All directors attended at least 75% of board meetings in fiscal 2025.
Latest events from Sono-Tek
- Leadership in ultrasonic coatings, global reach, and scalable solutions drive growth.SOTK
Planet MicroCap Showcase: VEGAS 20253 Feb 2026 - 4% revenue growth to $20.5M, $1.27M net income, and strong backlog support near-term growth.SOTK
Q4 20253 Feb 2026 - Record backlog and clean energy demand drive double-digit first half growth and profitability.SOTK
Q2 202519 Jan 2026 - Record backlog and 50% gross margin drive 24% net income growth despite flat sales.SOTK
Q3 202613 Jan 2026 - Record backlog and high-value system sales drive growth in clean energy and tech markets.SOTK
21st Virtual Investor Summit Microcap Event13 Jan 2026 - Record revenue, 150% medical sales growth, and 50% backlog increase offset sector declines.SOTK
Q2 20267 Jan 2026 - Proxy covers director elections, auditor ratification, and executive pay, with focus on governance and oversight.SOTK
Proxy Filing1 Dec 2025 - Net income rose 47% to $485K as gross margin hit 52% on strong clean energy demand.SOTK
Q1 202610 Jul 2025 - Net income surged on 40% sales growth, led by medical and clean energy demand.SOTK
Q1 202513 Jun 2025